Company Filing History:
Years Active: 2025
Title: Adam D. Durbin: Innovator in Cancer Research
Introduction
Adam D. Durbin is a notable inventor based in Memphis, TN (US). He has made significant contributions to the field of cancer research through his innovative work. His expertise lies in the development of compounds that target specific proteins involved in disease progression.
Latest Patents
Adam D. Durbin holds a patent for "Acetylation writer inhibitor development and uses thereof." This patent discloses bifunctional compounds, known as degraders, that specifically target HAT EP300 for degradation. The patent also includes pharmaceutical compositions containing these degraders and outlines methods for using the compounds to treat various diseases.
Career Highlights
Durbin is currently associated with the Dana-Farber Cancer Institute Inc., where he continues to advance his research in cancer treatment. His work is pivotal in developing new therapeutic strategies that could potentially improve patient outcomes.
Collaborations
He collaborates with Jun Qi, a fellow researcher, to further enhance the impact of their work in the field of cancer research.
Conclusion
Adam D. Durbin's innovative contributions to cancer research through his patent and work at the Dana-Farber Cancer Institute Inc. highlight his commitment to advancing medical science. His efforts in developing targeted therapies are crucial in the ongoing fight against cancer.